Unlock stock picks and a broker-level newsfeed that powers Wall Street.
60.91
+0.36
+(0.59%)
At close: April 1 at 4:00:01 PM EDT
62.00
+1.09
+(1.79%)
Pre-Market: 4:17:29 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 13 | 19 | 16 |
| Avg. Estimate | 1.07 | 1.46 | 5.83 | 6.71 |
| Low Estimate | 0.76 | 1.3 | 4.84 | 3.68 |
| High Estimate | 1.33 | 1.68 | 6.7 | 8.69 |
| Year Ago EPS | 0.64 | -1.82 | 1.08 | 5.83 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 17 | 23 | 22 |
| Avg. Estimate | 996.17M | 1.15B | 4.66B | 5.13B |
| Low Estimate | 918.51M | 1.1B | 4.55B | 4.78B |
| High Estimate | 1.1B | 1.21B | 4.81B | 5.51B |
| Year Ago Sales | 880.89M | 1.04B | 4.24B | 4.66B |
| Sales Growth (year/est) | 13.09% | 10.37% | 9.96% | 9.92% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.83 | 1.11 | 1.09 | 1.55 |
| EPS Actual | 0.64 | -1.82 | 1.07 | 1.43 |
| Difference | -0.19 | -2.93 | -0.02 | -0.12 |
| Surprise % | -23.09% | -264.53% | -2.03% | -8.01% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.07 | 1.46 | 5.83 | 6.71 |
| 7 Days Ago | 1.05 | 1.46 | 5.88 | 6.7 |
| 30 Days Ago | 1.05 | 1.46 | 5.74 | 6.72 |
| 60 Days Ago | 1.09 | 1.5 | 6.05 | 7.51 |
| 90 Days Ago | 1.07 | 1.46 | 6.08 | 7.68 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 3 |
| Up Last 30 Days | -- | 1 | 2 | 3 |
| Down Last 7 Days | 1 | 1 | 2 | 1 |
| Down Last 30 Days | 1 | 1 | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INCY | 66.76% | 180.11% | 439.82% | 15.02% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/24/2025 |
| Maintains | Truist Securities: Hold to Hold | 3/18/2025 |
| Downgrade | Guggenheim: Buy to Neutral | 3/18/2025 |
| Downgrade | William Blair: Outperform to Market Perform | 3/18/2025 |
| Reiterates | Citizens Capital Markets: Market Perform to Market Perform | 3/11/2025 |
| Reiterates | JMP Securities: Market Perform to Market Perform | 2/11/2025 |
Related Tickers
BMRN BioMarin Pharmaceutical Inc.
67.94
-3.89%
EXEL Exelixis, Inc.
36.39
-1.44%
MDGL Madrigal Pharmaceuticals, Inc.
323.98
-2.19%
ACAD ACADIA Pharmaceuticals Inc.
16.32
-1.75%
INSM Insmed Incorporated
72.00
-5.62%
AKRO Akero Therapeutics, Inc.
38.64
-4.55%
GMAB Genmab A/S
18.66
-4.70%
CYTK Cytokinetics, Incorporated
37.50
-6.69%
IONS Ionis Pharmaceuticals, Inc.
27.26
-9.65%
ALNY Alnylam Pharmaceuticals, Inc.
255.76
-5.28%